Jeff Yass’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.7M | Buy |
277,100
+269,100
| +3,364% | +$13.7M | ﹤0.01% | 2918 |
|
|
2026
Q1 | $427K | Sell |
8,000
-27,800
| -78% | -$1.63M | ﹤0.01% | 10051 |
|
|
2025
Q4 | $2.22M | Buy |
35,800
+6,900
| +24% | +$426K | ﹤0.01% | 5430 |
|
|
2025
Q3 | $1.74M | Sell |
28,900
-22,800
| -44% | -$1.39M | ﹤0.01% | 6097 |
|
|
2025
Q2 | $3.24M | Buy |
51,700
+34,900
| +208% | +$2.1M | ﹤0.01% | 4819 |
|
|
2025
Q1 | $1.01M | Sell |
16,800
-105,900
| -86% | -$6.58M | ﹤0.01% | 7235 |
|
|
2024
Q4 | $7.16M | Buy |
122,700
+43,900
| +56% | +$2.61M | ﹤0.01% | 3077 |
|
|
2024
Q3 | $4.67M | Buy |
78,800
+7,000
| +10% | +$400K | ﹤0.01% | 3694 |
|
|
2024
Q2 | $4.02M | Buy |
71,800
+33,800
| +89% | +$1.89M | ﹤0.01% | 3803 |
|
|
2024
Q1 | $2.23M | Sell |
38,000
-44,400
| -54% | -$2.51M | ﹤0.01% | 5073 |
|
|
2023
Q4 | $4.45M | Buy |
82,400
+24,600
| +43% | +$1.2M | ﹤0.01% | 3907 |
|
|
2023
Q3 | $2.8M | Buy |
57,800
+8,000
| +16% | +$425K | ﹤0.01% | 4508 |
|
|
2023
Q2 | $2.81M | Sell |
49,800
-12,200
| -20% | -$672K | ﹤0.01% | 4482 |
|
|
2023
Q1 | $3.35M | Sell |
62,000
-464,400
| -88% | -$24.7M | ﹤0.01% | 4103 |
|
|
2022
Q4 | $27.7M | Buy |
526,400
+416,000
| +377% | +$21.1M | 0.01% | 1254 |
|
|
2022
Q3 | $5.21M | Buy |
110,400
+7,700
| +7% | +$400K | ﹤0.01% | 3094 |
|
|
2022
Q2 | $5.18M | Buy |
102,700
+54,200
| +112% | +$2.95M | ﹤0.01% | 3127 |
|
|
2022
Q1 | $2.96M | Sell |
48,500
-13,200
| -21% | -$787K | ﹤0.01% | 4652 |
|
|
2021
Q4 | $4.06M | Sell |
61,700
-74,300
| -55% | -$4.76M | ﹤0.01% | 4103 |
|
|
2021
Q3 | $8.54M | Sell |
136,000
-100,400
| -42% | -$6.41M | ﹤0.01% | 3105 |
|
|
2021
Q2 | $14.2M | Buy |
236,400
+9,600
| +4% | +$555K | ﹤0.01% | 2434 |
|
|
2021
Q1 | $12.5M | Sell |
226,800
-19,800
| -8% | -$1.1M | ﹤0.01% | 2447 |
|
|
2020
Q4 | $13.5M | Buy |
246,600
+94,200
| +62% | +$4.92M | ﹤0.01% | 2148 |
|
|
2020
Q3 | $7.61M | Sell |
152,400
-279,000
| -65% | -$13.5M | ﹤0.01% | 2534 |
|
|
2020
Q2 | $19M | Sell |
431,400
-77,400
| -15% | -$3.31M | ﹤0.01% | 1467 |
|
|
2020
Q1 | $19.1M | Buy |
508,800
+370,200
| +267% | +$15.6M | 0.01% | 1204 |
|
|
2019
Q4 | $6.11M | Buy |
138,600
+5,400
| +4% | +$227K | ﹤0.01% | 2709 |
|
|
2019
Q3 | $5.49M | Sell |
133,200
-555,000
| -81% | -$22.7M | ﹤0.01% | 2604 |
|
|
2019
Q2 | $27.6M | Buy |
688,200
+619,800
| +906% | +$23.5M | 0.01% | 1066 |
|
|
2019
Q1 | $2.64M | Buy |
68,400
+48,600
| +245% | +$1.76M | ﹤0.01% | 3342 |
|
|
2018
Q4 | $659K | Buy |
+19,800
| New | +$686K | ﹤0.01% | 5484 |
|
Other funds holding IHI
AAS
Jeff Yass's IHI Position: Q2 2026 in Review
Jeff Yass increased its iShares US Medical Devices ETF (IHI) stake by 553% in Q2 2026, buying an estimated $13.6M and bringing the position to 316,762 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2741.
Jeff Yass first reported a position in IHI in Q4 2013 and has held it in 45 quarters since. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Jeff Yass held 316,762 shares of iShares US Medical Devices ETF worth $15.7M as of Q2 2026.
- Jeff Yass bought 268,231 iShares US Medical Devices ETF shares in Q2 2026, an estimated $13.6M.
- iShares US Medical Devices ETF made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #2741 holding.
- Jeff Yass first reported a position in iShares US Medical Devices ETF in Q4 2013 and has held it in 45 quarters since.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.